Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.66
+0.03 (0.28%)
May 19, 2026, 4:00 PM EDT - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $890.48 million as of May 19, 2026. Its market cap has increased by 83.18% in one year.
Market Cap
890.48M
Enterprise Value
1.14B
1-Year Change
83.18%
Ranking
Category
Stock Price
$10.66
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $890.48M, an increase of 24.81%. That is a compound annual growth rate of 4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 720.16M | 44.52% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inspire Medical Systems | 1.21B |
| Avanos Medical | 1.16B |
| Artivion | 1.15B |
| IRADIMED CORPORATION | 1.13B |
| CONMED | 1.10B |
| Integra LifeSciences Holdings | 1.10B |
| Butterfly Network | 1.00B |
| Tandem Diabetes Care | 927.20M |